2017 ASH Annual Meeting

Come and Meet our partner Phosplatin Therapeutics next week at the 59th ASH Annual Meeting in Atlanta, GA to discover how Mass Spectrometry Imaging can effectively accompany clinical investigations. You will discover how MSI can reveal the presence of PT-112 derived Platinium in several target tissues with a special focus in bone tissues. A revolutionary method to understand better biodistribution!

Translational Research of PT-112, a Clinical Agent in Advanced Phase I Development: Evident Bone Tropism, Synergy In Vitro with Bortezomib and Lenalidomide, and Potent Efficacy in the Vk*MYC Mouse Model of Multiple Myeloma.



Search news